OTC Drugs, Medical Devices and Diagnostics Market Analysis and Key Player Shares to 2029, Featuring Haleon Group of Co., Kenvue, Sanofi, and Bayer Among Others
Rise in the Number of Diseases are Creating a Constant Need for OTC Drugs, Medical Devices, and Diagnostics for Disease Management
OTC Drugs, Medical Devices and Diagnostics Market
OTC Drugs, Medical Devices and Diagnostics Market
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) — The “OTC Drugs, Medical Devices and Diagnostics Market” report has been added to ResearchAndMarkets.com’s offering.
The OTC Drugs, Medical Devices and Diagnostics Market was valued at USD 251.7 billion in 2024, and is expected to reach USD 359.7 billion by 2029, rising at a CAGR of 7.40%.
Report Scope
This report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics based on products and applications. Based on product, OTC drugs, medical devices, and diagnostics are categorized into OTC drugs (pharmaceutical drugs and vitamin and mineral supplements) and OTC devices and diagnostics (monitoring devices, therapeutic devices, and diagnostic devices and kits). Based on application, the report is segmented into respiratory disorders, orthopedic diseases, gastrointestinal disorders, diabetes, obesity, cardiovascular diseases, ENT disorders, skin disorders, sleep disorders, and other disorders.
The report includes:
36 data tables and 69 additional tables
An up-to-date overview of the global markets for OTC drugs, medical devices and diagnostics
Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by product type, application, and geographic region
Discussion of how the rise in the number of diseases are creating a constant need for OTC drugs, medical devices, and diagnostics for disease management
A look at the key market drivers and restraints that will shape the market for OTC drugs, medical devices, and diagnostics over the next five years (2024-2029)
A discussion on ESG challenges and practices in the industry
Review of patents issued for OTC drugs, medical devices, and diagnostics
Assessment of the vendor landscape, including the market shares of leading companies, their product portfolios and financial overviews
Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
Company profiles of major players within the industry, including Haleon Group of Co., Kenvue, Sanofi, and Bayer AG
Key Attributes
Report Attribute
Details
No. of Pages
139
Forecast Period
2024-2029
Estimated Market Value (USD) in 2024
$251.7 Billion
Forecasted Market Value (USD) by 2029
$359.7 Billion
Compound Annual Growth Rate
7.4%
Regions Covered
Global
Key Topics Covered
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Introduction
Types of OTC Products
Pharmaceutical OTC Drugs
Vitamin and Mineral Supplements
OTC Medical Devices and Diagnostics
Advantages and Disadvantages of OTC Drugs, Medical Devices, and Diagnostics
Cost Savings Analysis
PESTLE Analysis
Porter’s Five Forces Analysis
Bargaining Power of Buyers: High
Bargaining Power of Suppliers: Moderate
Potential of New Entrants to the Market: Moderate
Competition in the Industry: High
Threat of Substitutes: Moderate to High
Regulatory Landscape
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Growing Prevalence of Chronic Diseases and Expanding Geriatric Populations
Increasing Health Awareness
Growing Online Sales Channels and Telehealth Platforms
Market Restraints
Presence of Alternative Methods
Market Opportunities
Emerging Economies
Market Challenges
Misuse and Interactions of OTC Drugs and Medical Devices
Data Privacy and Security Concerns
Chapter 4 Emerging Technologies and Developments
Emerging Technologies
Advanced Drug Delivery
Advanced Wearable Sensors
Artificial Intelligence
Clinical Trials Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product
OTC Drugs
Pharmaceutical Drugs
Vitamin and Mineral Supplements
OTC Devices and Diagnostics
Monitoring Devices
Therapeutic Devices
Diagnostic Devices and Kits
Market Breakdown by Application
Respiratory Disorders
Gastrointestinal Disorders
Orthopedic Diseases
Cardiovascular Diseases
Diabetes
Skin Disorders
Obesity
ENT Disorders
Sleep Disorders
Other Disorders
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Market Analysis
Strategic Analysis
Chapter 7 Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective
Introduction to ESG
Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective
Key ESG Issues
OTC Drug, Medical Device, and Diagnostics ESG Performance Analysis
Concluding Remarks
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Companies profiled in this OTC Drugs, Medical Devices and Diagnostics Market report:
Abbott
Bayer AG
DSM-Firmenich
Haleon Group of Co.
Kenvue
Koninklijke Philips N.V.
Masimo
Nestle
Procter & Gamble
Sanofi
For more information about this report visit
About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900